カテゴリ： 世界, 医療/バイオ, QYResearch

ヒト由来無細胞＆真皮置換の世界市場2023年：ヒト真皮、ヒト胎盤膜

■ 英語タイトル：Global Acellular and Dermal Replacement from Human Source Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7584）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7584
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒト由来無細胞＆真皮置換の世界市場2023年：ヒト真皮、ヒト胎盤膜]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はヒト由来無細胞＆真皮置換のグローバル市場について調査・分析し、世界のヒト由来無細胞＆真皮置換市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ヒト真皮、ヒト胎盤膜）、用途別セグメント分析（病院、診療所）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologicsなどが含まれています。ヒト由来無細胞＆真皮置換のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ヒト由来無細胞＆真皮置換市場規模を算出する際に考慮しました。

・ヒト由来無細胞＆真皮置換市場の概要
- 製品の定義
- ヒト由来無細胞＆真皮置換の種類別セグメント
- 世界のヒト由来無細胞＆真皮置換市場規模：タイプ別分析（ヒト真皮、ヒト胎盤膜）
- ヒト由来無細胞＆真皮置換の用途別セグメント
- 世界のヒト由来無細胞＆真皮置換市場規模：用途別分析（病院、診療所）
- 世界のヒト由来無細胞＆真皮置換市場規模予測（2018年-2029年）
- ヒト由来無細胞＆真皮置換の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ヒト由来無細胞＆真皮置換市場の競争状況およびトレンド

・ヒト由来無細胞＆真皮置換の地域別市場規模
- 北米のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- 米国のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- ヨーロッパのヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- アジア太平洋のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- 中国のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- 日本のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- 韓国のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- インドのヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- オーストラリアのヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- 中南米のヒト由来無細胞＆真皮置換市場規模（2018年-2029年）
- 中東・アフリカのヒト由来無細胞＆真皮置換市場規模（2018年-2029年）

・種類別セグメント：ヒト真皮、ヒト胎盤膜
- 世界のヒト由来無細胞＆真皮置換のタイプ別販売量（2018年-2023年）
- 世界のヒト由来無細胞＆真皮置換のタイプ別売上（2018年-2023年）
- 世界のヒト由来無細胞＆真皮置換のタイプ別価格

・用途別セグメント：病院、診療所
- 世界のヒト由来無細胞＆真皮置換の用途別販売量（2018年-2023年）
- 世界のヒト由来無細胞＆真皮置換の用途別売上（2018年-2023年）
- 世界のヒト由来無細胞＆真皮置換の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologics

・産業チェーンと販売チャネルの分析
- ヒト由来無細胞＆真皮置換産業チェーン分析
- ヒト由来無細胞＆真皮置換の主要原材料
- ヒト由来無細胞＆真皮置換の販売チャネル
- ヒト由来無細胞＆真皮置換のディストリビューター
- ヒト由来無細胞＆真皮置換の主要顧客

・ヒト由来無細胞＆真皮置換市場ダイナミクス
- ヒト由来無細胞＆真皮置換の業界動向
- ヒト由来無細胞＆真皮置換市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Acellular and Dermal Replacement from Human Source market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Acellular and Dermal Replacement from Human Source is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Acellular and Dermal Replacement from Human Source is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Acellular and Dermal Replacement from Human Source include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, Gunze, Tissue Regenix, Zimmer Biomet, Integra LifeSciences and Organogenesis, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acellular and Dermal Replacement from Human Source, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acellular and Dermal Replacement from Human Source.
The Acellular and Dermal Replacement from Human Source market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acellular and Dermal Replacement from Human Source market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acellular and Dermal Replacement from Human Source manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
Segment by Type
Human Dermis
Human Placental Membrane
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acellular and Dermal Replacement from Human Source manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acellular and Dermal Replacement from Human Source in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Acellular and Dermal Replacement from Human Source Market Overview
1.1 Product Overview and Scope of Acellular and Dermal Replacement from Human Source
1.2 Acellular and Dermal Replacement from Human Source Segment by Type
1.2.1 Global Acellular and Dermal Replacement from Human Source Market Value Comparison by Type (2023-2029)
1.2.2 Human Dermis
1.2.3 Human Placental Membrane
1.3 Acellular and Dermal Replacement from Human Source Segment by Application
1.3.1 Global Acellular and Dermal Replacement from Human Source Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Acellular and Dermal Replacement from Human Source Market Size Estimates and Forecasts
1.4.1 Global Acellular and Dermal Replacement from Human Source Revenue 2018-2029
1.4.2 Global Acellular and Dermal Replacement from Human Source Sales 2018-2029
1.4.3 Global Acellular and Dermal Replacement from Human Source Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Acellular and Dermal Replacement from Human Source Market Competition by Manufacturers
2.1 Global Acellular and Dermal Replacement from Human Source Sales Market Share by Manufacturers (2018-2023)
2.2 Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Acellular and Dermal Replacement from Human Source Average Price by Manufacturers (2018-2023)
2.4 Global Acellular and Dermal Replacement from Human Source Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Acellular and Dermal Replacement from Human Source, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acellular and Dermal Replacement from Human Source, Product Type & Application
2.7 Acellular and Dermal Replacement from Human Source Market Competitive Situation and Trends
2.7.1 Acellular and Dermal Replacement from Human Source Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acellular and Dermal Replacement from Human Source Players Market Share by Revenue
2.7.3 Global Acellular and Dermal Replacement from Human Source Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acellular and Dermal Replacement from Human Source Retrospective Market Scenario by Region
3.1 Global Acellular and Dermal Replacement from Human Source Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Acellular and Dermal Replacement from Human Source Global Acellular and Dermal Replacement from Human Source Sales by Region: 2018-2029
3.2.1 Global Acellular and Dermal Replacement from Human Source Sales by Region: 2018-2023
3.2.2 Global Acellular and Dermal Replacement from Human Source Sales by Region: 2024-2029
3.3 Global Acellular and Dermal Replacement from Human Source Global Acellular and Dermal Replacement from Human Source Revenue by Region: 2018-2029
3.3.1 Global Acellular and Dermal Replacement from Human Source Revenue by Region: 2018-2023
3.3.2 Global Acellular and Dermal Replacement from Human Source Revenue by Region: 2024-2029
3.4 North America Acellular and Dermal Replacement from Human Source Market Facts & Figures by Country
3.4.1 North America Acellular and Dermal Replacement from Human Source Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Acellular and Dermal Replacement from Human Source Sales by Country (2018-2029)
3.4.3 North America Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acellular and Dermal Replacement from Human Source Market Facts & Figures by Country
3.5.1 Europe Acellular and Dermal Replacement from Human Source Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Acellular and Dermal Replacement from Human Source Sales by Country (2018-2029)
3.5.3 Europe Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acellular and Dermal Replacement from Human Source Market Facts & Figures by Country
3.6.1 Asia Pacific Acellular and Dermal Replacement from Human Source Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Acellular and Dermal Replacement from Human Source Sales by Country (2018-2029)
3.6.3 Asia Pacific Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acellular and Dermal Replacement from Human Source Market Facts & Figures by Country
3.7.1 Latin America Acellular and Dermal Replacement from Human Source Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Acellular and Dermal Replacement from Human Source Sales by Country (2018-2029)
3.7.3 Latin America Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acellular and Dermal Replacement from Human Source Market Facts & Figures by Country
3.8.1 Middle East and Africa Acellular and Dermal Replacement from Human Source Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Acellular and Dermal Replacement from Human Source Sales by Country (2018-2029)
3.8.3 Middle East and Africa Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Acellular and Dermal Replacement from Human Source Sales by Type (2018-2029)
4.1.1 Global Acellular and Dermal Replacement from Human Source Sales by Type (2018-2023)
4.1.2 Global Acellular and Dermal Replacement from Human Source Sales by Type (2024-2029)
4.1.3 Global Acellular and Dermal Replacement from Human Source Sales Market Share by Type (2018-2029)
4.2 Global Acellular and Dermal Replacement from Human Source Revenue by Type (2018-2029)
4.2.1 Global Acellular and Dermal Replacement from Human Source Revenue by Type (2018-2023)
4.2.2 Global Acellular and Dermal Replacement from Human Source Revenue by Type (2024-2029)
4.2.3 Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Type (2018-2029)
4.3 Global Acellular and Dermal Replacement from Human Source Price by Type (2018-2029)
5 Segment by Application
5.1 Global Acellular and Dermal Replacement from Human Source Sales by Application (2018-2029)
5.1.1 Global Acellular and Dermal Replacement from Human Source Sales by Application (2018-2023)
5.1.2 Global Acellular and Dermal Replacement from Human Source Sales by Application (2024-2029)
5.1.3 Global Acellular and Dermal Replacement from Human Source Sales Market Share by Application (2018-2029)
5.2 Global Acellular and Dermal Replacement from Human Source Revenue by Application (2018-2029)
5.2.1 Global Acellular and Dermal Replacement from Human Source Revenue by Application (2018-2023)
5.2.2 Global Acellular and Dermal Replacement from Human Source Revenue by Application (2024-2029)
5.2.3 Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Application (2018-2029)
5.3 Global Acellular and Dermal Replacement from Human Source Price by Application (2018-2029)
6 Key Companies Profiled
6.1 MTF Biologics
6.1.1 MTF Biologics Corporation Information
6.1.2 MTF Biologics Description and Business Overview
6.1.3 MTF Biologics Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.1.4 MTF Biologics Acellular and Dermal Replacement from Human Source Product Portfolio
6.1.5 MTF Biologics Recent Developments/Updates
6.2 Allosource
6.2.1 Allosource Corporation Information
6.2.2 Allosource Description and Business Overview
6.2.3 Allosource Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Allosource Acellular and Dermal Replacement from Human Source Product Portfolio
6.2.5 Allosource Recent Developments/Updates
6.3 Parametrics Medical
6.3.1 Parametrics Medical Corporation Information
6.3.2 Parametrics Medical Description and Business Overview
6.3.3 Parametrics Medical Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Parametrics Medical Acellular and Dermal Replacement from Human Source Product Portfolio
6.3.5 Parametrics Medical Recent Developments/Updates
6.4 LifeNet Health
6.4.1 LifeNet Health Corporation Information
6.4.2 LifeNet Health Description and Business Overview
6.4.3 LifeNet Health Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LifeNet Health Acellular and Dermal Replacement from Human Source Product Portfolio
6.4.5 LifeNet Health Recent Developments/Updates
6.5 Gunze
6.5.1 Gunze Corporation Information
6.5.2 Gunze Description and Business Overview
6.5.3 Gunze Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gunze Acellular and Dermal Replacement from Human Source Product Portfolio
6.5.5 Gunze Recent Developments/Updates
6.6 Tissue Regenix
6.6.1 Tissue Regenix Corporation Information
6.6.2 Tissue Regenix Description and Business Overview
6.6.3 Tissue Regenix Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tissue Regenix Acellular and Dermal Replacement from Human Source Product Portfolio
6.6.5 Tissue Regenix Recent Developments/Updates
6.7 Zimmer Biomet
6.6.1 Zimmer Biomet Corporation Information
6.6.2 Zimmer Biomet Description and Business Overview
6.6.3 Zimmer Biomet Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Acellular and Dermal Replacement from Human Source Product Portfolio
6.7.5 Zimmer Biomet Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Corporation Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Integra LifeSciences Acellular and Dermal Replacement from Human Source Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 Organogenesis
6.9.1 Organogenesis Corporation Information
6.9.2 Organogenesis Description and Business Overview
6.9.3 Organogenesis Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Organogenesis Acellular and Dermal Replacement from Human Source Product Portfolio
6.9.5 Organogenesis Recent Developments/Updates
6.10 Flower Orthopedics
6.10.1 Flower Orthopedics Corporation Information
6.10.2 Flower Orthopedics Description and Business Overview
6.10.3 Flower Orthopedics Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Flower Orthopedics Acellular and Dermal Replacement from Human Source Product Portfolio
6.10.5 Flower Orthopedics Recent Developments/Updates
6.11 Promethean
6.11.1 Promethean Corporation Information
6.11.2 Promethean Acellular and Dermal Replacement from Human Source Description and Business Overview
6.11.3 Promethean Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Promethean Acellular and Dermal Replacement from Human Source Product Portfolio
6.11.5 Promethean Recent Developments/Updates
6.12 Wright Medical Group
6.12.1 Wright Medical Group Corporation Information
6.12.2 Wright Medical Group Acellular and Dermal Replacement from Human Source Description and Business Overview
6.12.3 Wright Medical Group Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wright Medical Group Acellular and Dermal Replacement from Human Source Product Portfolio
6.12.5 Wright Medical Group Recent Developments/Updates
6.13 Aziyo Biologics
6.13.1 Aziyo Biologics Corporation Information
6.13.2 Aziyo Biologics Acellular and Dermal Replacement from Human Source Description and Business Overview
6.13.3 Aziyo Biologics Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aziyo Biologics Acellular and Dermal Replacement from Human Source Product Portfolio
6.13.5 Aziyo Biologics Recent Developments/Updates
6.14 RTI Surgical
6.14.1 RTI Surgical Corporation Information
6.14.2 RTI Surgical Acellular and Dermal Replacement from Human Source Description and Business Overview
6.14.3 RTI Surgical Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.14.4 RTI Surgical Acellular and Dermal Replacement from Human Source Product Portfolio
6.14.5 RTI Surgical Recent Developments/Updates
6.15 MiMedx Group
6.15.1 MiMedx Group Corporation Information
6.15.2 MiMedx Group Acellular and Dermal Replacement from Human Source Description and Business Overview
6.15.3 MiMedx Group Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.15.4 MiMedx Group Acellular and Dermal Replacement from Human Source Product Portfolio
6.15.5 MiMedx Group Recent Developments/Updates
6.16 Tides Medical
6.16.1 Tides Medical Corporation Information
6.16.2 Tides Medical Acellular and Dermal Replacement from Human Source Description and Business Overview
6.16.3 Tides Medical Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Tides Medical Acellular and Dermal Replacement from Human Source Product Portfolio
6.16.5 Tides Medical Recent Developments/Updates
6.17 Ventris Medical
6.17.1 Ventris Medical Corporation Information
6.17.2 Ventris Medical Acellular and Dermal Replacement from Human Source Description and Business Overview
6.17.3 Ventris Medical Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Ventris Medical Acellular and Dermal Replacement from Human Source Product Portfolio
6.17.5 Ventris Medical Recent Developments/Updates
6.18 Vivex Biomedical
6.18.1 Vivex Biomedical Corporation Information
6.18.2 Vivex Biomedical Acellular and Dermal Replacement from Human Source Description and Business Overview
6.18.3 Vivex Biomedical Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Vivex Biomedical Acellular and Dermal Replacement from Human Source Product Portfolio
6.18.5 Vivex Biomedical Recent Developments/Updates
6.19 Aedicell
6.19.1 Aedicell Corporation Information
6.19.2 Aedicell Acellular and Dermal Replacement from Human Source Description and Business Overview
6.19.3 Aedicell Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Aedicell Acellular and Dermal Replacement from Human Source Product Portfolio
6.19.5 Aedicell Recent Developments/Updates
6.20 Amniox Medical
6.20.1 Amniox Medical Corporation Information
6.20.2 Amniox Medical Acellular and Dermal Replacement from Human Source Description and Business Overview
6.20.3 Amniox Medical Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Amniox Medical Acellular and Dermal Replacement from Human Source Product Portfolio
6.20.5 Amniox Medical Recent Developments/Updates
6.21 StimLabs
6.21.1 StimLabs Corporation Information
6.21.2 StimLabs Acellular and Dermal Replacement from Human Source Description and Business Overview
6.21.3 StimLabs Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.21.4 StimLabs Acellular and Dermal Replacement from Human Source Product Portfolio
6.21.5 StimLabs Recent Developments/Updates
6.22 Skye Biologics
6.22.1 Skye Biologics Corporation Information
6.22.2 Skye Biologics Acellular and Dermal Replacement from Human Source Description and Business Overview
6.22.3 Skye Biologics Acellular and Dermal Replacement from Human Source Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Skye Biologics Acellular and Dermal Replacement from Human Source Product Portfolio
6.22.5 Skye Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acellular and Dermal Replacement from Human Source Industry Chain Analysis
7.2 Acellular and Dermal Replacement from Human Source Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acellular and Dermal Replacement from Human Source Production Mode & Process
7.4 Acellular and Dermal Replacement from Human Source Sales and Marketing
7.4.1 Acellular and Dermal Replacement from Human Source Sales Channels
7.4.2 Acellular and Dermal Replacement from Human Source Distributors
7.5 Acellular and Dermal Replacement from Human Source Customers
8 Acellular and Dermal Replacement from Human Source Market Dynamics
8.1 Acellular and Dermal Replacement from Human Source Industry Trends
8.2 Acellular and Dermal Replacement from Human Source Market Drivers
8.3 Acellular and Dermal Replacement from Human Source Market Challenges
8.4 Acellular and Dermal Replacement from Human Source Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Acellular and Dermal Replacement from Human Source Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Acellular and Dermal Replacement from Human Source Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Acellular and Dermal Replacement from Human Source Market Competitive Situation by Manufacturers in 2022
Table 4. Global Acellular and Dermal Replacement from Human Source Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Acellular and Dermal Replacement from Human Source Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Acellular and Dermal Replacement from Human Source Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Acellular and Dermal Replacement from Human Source Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Acellular and Dermal Replacement from Human Source, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Acellular and Dermal Replacement from Human Source, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Acellular and Dermal Replacement from Human Source, Product Type & Application
Table 12. Global Key Manufacturers of Acellular and Dermal Replacement from Human Source, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Acellular and Dermal Replacement from Human Source by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acellular and Dermal Replacement from Human Source as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Acellular and Dermal Replacement from Human Source Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Acellular and Dermal Replacement from Human Source Sales by Region (2018-2023) & (K Units)
Table 18. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Region (2018-2023)
Table 19. Global Acellular and Dermal Replacement from Human Source Sales by Region (2024-2029) & (K Units)
Table 20. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Region (2024-2029)
Table 21. Global Acellular and Dermal Replacement from Human Source Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Region (2018-2023)
Table 23. Global Acellular and Dermal Replacement from Human Source Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Region (2024-2029)
Table 25. North America Acellular and Dermal Replacement from Human Source Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Acellular and Dermal Replacement from Human Source Sales by Country (2018-2023) & (K Units)
Table 27. North America Acellular and Dermal Replacement from Human Source Sales by Country (2024-2029) & (K Units)
Table 28. North America Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Acellular and Dermal Replacement from Human Source Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Acellular and Dermal Replacement from Human Source Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Acellular and Dermal Replacement from Human Source Sales by Country (2018-2023) & (K Units)
Table 32. Europe Acellular and Dermal Replacement from Human Source Sales by Country (2024-2029) & (K Units)
Table 33. Europe Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Acellular and Dermal Replacement from Human Source Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Acellular and Dermal Replacement from Human Source Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Acellular and Dermal Replacement from Human Source Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Acellular and Dermal Replacement from Human Source Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Acellular and Dermal Replacement from Human Source Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Acellular and Dermal Replacement from Human Source Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Acellular and Dermal Replacement from Human Source Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Acellular and Dermal Replacement from Human Source Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Acellular and Dermal Replacement from Human Source Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Acellular and Dermal Replacement from Human Source Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Acellular and Dermal Replacement from Human Source Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Acellular and Dermal Replacement from Human Source Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Acellular and Dermal Replacement from Human Source Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Acellular and Dermal Replacement from Human Source Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Acellular and Dermal Replacement from Human Source Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Acellular and Dermal Replacement from Human Source Sales (K Units) by Type (2018-2023)
Table 51. Global Acellular and Dermal Replacement from Human Source Sales (K Units) by Type (2024-2029)
Table 52. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Type (2018-2023)
Table 53. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Type (2024-2029)
Table 54. Global Acellular and Dermal Replacement from Human Source Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Acellular and Dermal Replacement from Human Source Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Type (2018-2023)
Table 57. Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Type (2024-2029)
Table 58. Global Acellular and Dermal Replacement from Human Source Price (US$/Unit) by Type (2018-2023)
Table 59. Global Acellular and Dermal Replacement from Human Source Price (US$/Unit) by Type (2024-2029)
Table 60. Global Acellular and Dermal Replacement from Human Source Sales (K Units) by Application (2018-2023)
Table 61. Global Acellular and Dermal Replacement from Human Source Sales (K Units) by Application (2024-2029)
Table 62. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Application (2018-2023)
Table 63. Global Acellular and Dermal Replacement from Human Source Sales Market Share by Application (2024-2029)
Table 64. Global Acellular and Dermal Replacement from Human Source Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Acellular and Dermal Replacement from Human Source Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Application (2018-2023)
Table 67. Global Acellular and Dermal Replacement from Human Source Revenue Market Share by Application (2024-2029)
Table 68. Global Acellular and Dermal Replacement from Human Source Price (US$/Unit) by Application (2018-2023)
Table 69. Global Acellular and Dermal Replacement from Human Source Price (US$/Unit) by Application (2024-2029)
Table 70. MTF Biologics Corporation Information
Table 71. MTF Biologics Description and Business Overview
Table 72. MTF Biologics Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. MTF Biologics Acellular and Dermal Replacement from Human Source Product
Table 74. MTF Biologics Recent Developments/Updates
Table 75. Allosource Corporation Information
Table 76. Allosource Description and Business Overview
Table 77. Allosource Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Allosource Acellular and Dermal Replacement from Human Source Product
Table 79. Allosource Recent Developments/Updates
Table 80. Parametrics Medical Corporation Information
Table 81. Parametrics Medical Description and Business Overview
Table 82. Parametrics Medical Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Parametrics Medical Acellular and Dermal Replacement from Human Source Product
Table 84. Parametrics Medical Recent Developments/Updates
Table 85. LifeNet Health Corporation Information
Table 86. LifeNet Health Description and Business Overview
Table 87. LifeNet Health Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. LifeNet Health Acellular and Dermal Replacement from Human Source Product
Table 89. LifeNet Health Recent Developments/Updates
Table 90. Gunze Corporation Information
Table 91. Gunze Description and Business Overview
Table 92. Gunze Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Gunze Acellular and Dermal Replacement from Human Source Product
Table 94. Gunze Recent Developments/Updates
Table 95. Tissue Regenix Corporation Information
Table 96. Tissue Regenix Description and Business Overview
Table 97. Tissue Regenix Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Tissue Regenix Acellular and Dermal Replacement from Human Source Product
Table 99. Tissue Regenix Recent Developments/Updates
Table 100. Zimmer Biomet Corporation Information
Table 101. Zimmer Biomet Description and Business Overview
Table 102. Zimmer Biomet Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Zimmer Biomet Acellular and Dermal Replacement from Human Source Product
Table 104. Zimmer Biomet Recent Developments/Updates
Table 105. Integra LifeSciences Corporation Information
Table 106. Integra LifeSciences Description and Business Overview
Table 107. Integra LifeSciences Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Integra LifeSciences Acellular and Dermal Replacement from Human Source Product
Table 109. Integra LifeSciences Recent Developments/Updates
Table 110. Organogenesis Corporation Information
Table 111. Organogenesis Description and Business Overview
Table 112. Organogenesis Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Organogenesis Acellular and Dermal Replacement from Human Source Product
Table 114. Organogenesis Recent Developments/Updates
Table 115. Flower Orthopedics Corporation Information
Table 116. Flower Orthopedics Description and Business Overview
Table 117. Flower Orthopedics Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Flower Orthopedics Acellular and Dermal Replacement from Human Source Product
Table 119. Flower Orthopedics Recent Developments/Updates
Table 120. Promethean Corporation Information
Table 121. Promethean Description and Business Overview
Table 122. Promethean Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Promethean Acellular and Dermal Replacement from Human Source Product
Table 124. Promethean Recent Developments/Updates
Table 125. Wright Medical Group Corporation Information
Table 126. Wright Medical Group Description and Business Overview
Table 127. Wright Medical Group Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Wright Medical Group Acellular and Dermal Replacement from Human Source Product
Table 129. Wright Medical Group Recent Developments/Updates
Table 130. Aziyo Biologics Corporation Information
Table 131. Aziyo Biologics Description and Business Overview
Table 132. Aziyo Biologics Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Aziyo Biologics Acellular and Dermal Replacement from Human Source Product
Table 134. Aziyo Biologics Recent Developments/Updates
Table 135. RTI Surgical Corporation Information
Table 136. RTI Surgical Description and Business Overview
Table 137. RTI Surgical Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. RTI Surgical Acellular and Dermal Replacement from Human Source Product
Table 139. RTI Surgical Recent Developments/Updates
Table 140. MiMedx Group Corporation Information
Table 141. MiMedx Group Description and Business Overview
Table 142. MiMedx Group Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. MiMedx Group Acellular and Dermal Replacement from Human Source Product
Table 144. MiMedx Group Recent Developments/Updates
Table 145. Tides Medical Corporation Information
Table 146. Tides Medical Description and Business Overview
Table 147. Tides Medical Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Tides Medical Acellular and Dermal Replacement from Human Source Product
Table 149. Tides Medical Recent Developments/Updates
Table 150. Ventris Medical Corporation Information
Table 151. Ventris Medical Description and Business Overview
Table 152. Ventris Medical Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Ventris Medical Acellular and Dermal Replacement from Human Source Product
Table 154. Ventris Medical Recent Developments/Updates
Table 155. Vivex Biomedical Corporation Information
Table 156. Vivex Biomedical Description and Business Overview
Table 157. Vivex Biomedical Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Vivex Biomedical Acellular and Dermal Replacement from Human Source Product
Table 159. Vivex Biomedical Recent Developments/Updates
Table 160. Aedicell Corporation Information
Table 161. Aedicell Description and Business Overview
Table 162. Aedicell Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Aedicell Acellular and Dermal Replacement from Human Source Product
Table 164. Aedicell Recent Developments/Updates
Table 165. Amniox Medical Corporation Information
Table 166. Amniox Medical Description and Business Overview
Table 167. Amniox Medical Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Amniox Medical Acellular and Dermal Replacement from Human Source Product
Table 169. Amniox Medical Recent Developments/Updates
Table 170. StimLabs Corporation Information
Table 171. StimLabs Description and Business Overview
Table 172. StimLabs Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. StimLabs Acellular and Dermal Replacement from Human Source Product
Table 174. StimLabs Recent Developments/Updates
Table 175. Skye Biologics Corporation Information
Table 176. Skye Biologics Description and Business Overview
Table 177. Skye Biologics Acellular and Dermal Replacement from Human Source Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Skye Biologics Acellular and Dermal Replacement from Human Source Product
Table 179. Skye Biologics Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Acellular and Dermal Replacement from Human Source Distributors List
Table 183. Acellular and Dermal Replacement from Human Source Customers List
Table 184. Acellular and Dermal Replacement from Human Source Market Trends
Table 185. Acellular and Dermal Replacement from Human Source Market Drivers
Table 186. Acellular and Dermal Replacement from Human Source Market Challenges
Table 187. Acellular and Dermal Replacement from Human Source Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Acellular and Dermal Replacement from Human Source
Figure 2. Global Acellular and Dermal Replacement from Human Source Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Acellular and Dermal Replacement from Human Source Market Share by Type in 2022 & 2029
Figure 4. Human Dermis Product Picture
Figure 5. Human Placental Membrane Product Picture
Figure 6. Global Acellular and Dermal Replacement from Human Source Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Acellular and Dermal Replacement from Human Source Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Global Acellular and Dermal Replacement from Human Source Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Acellular and Dermal Replacement from Human Source Market Size (2018-2029) & (US$ Million)
Figure 12. Global Acellular and Dermal Replacement from Human Source Sales (2018-2029) & (K Units)
Figure 13. Global Acellular and Dermal Replacement from Human Source Average Price (US$/Unit) & (2018-2029)
Figure 14. Acellular and Dermal Replacement from Human Source Report Years Considered
Figure 15. Acellular and Dermal Replacement from Human Source Sales Share by Manufacturers in 2022
Figure 16. Global Acellular and Dermal Replacement from Human Source Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Acellular and Dermal Replacement from Human Source Players: Market Share by Revenue in 2022
Figure 18. Acellular and Dermal Replacement from Human Source Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Acellular and Dermal Replacement from Human Source Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Acellular and Dermal Replacement from Human Source Sales Market Share by Country (2018-2029)
Figure 21. North America Acellular and Dermal Replacement from Human Source Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Acellular and Dermal Replacement from Human Source Sales Market Share by Country (2018-2029)
Figure 25. Europe Acellular and Dermal Replacement from Human Source Revenue Market Share by Country (2018-2029)
Figure 26. Germany Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Acellular and Dermal Replacement from Human Source Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Acellular and Dermal Replacement from Human Source Revenue Market Share by Region (2018-2029)
Figure 33. China Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Acellular and Dermal Replacement from Human Source Sales Market Share by Country (2018-2029)
Figure 44. Latin America Acellular and Dermal Replacement from Human Source Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Acellular and Dermal Replacement from Human Source Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Acellular and Dermal Replacement from Human Source Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. U.A.E Acellular and Dermal Replacement from Human Source Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Acellular and Dermal Replacement from Human Source by Type (2018-2029)
Figure 54. Global Revenue Market Share of Acellular and Dermal Replacement from Human Source by Type (2018-2029)
Figure 55. Global Acellular and Dermal Replacement from Human Source Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Acellular and Dermal Replacement from Human Source by Application (2018-2029)
Figure 57. Global Revenue Market Share of Acellular and Dermal Replacement from Human Source by Application (2018-2029)
Figure 58. Global Acellular and Dermal Replacement from Human Source Price (US$/Unit) by Application (2018-2029)
Figure 59. Acellular and Dermal Replacement from Human Source Value Chain
Figure 60. Acellular and Dermal Replacement from Human Source Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 人工皮膚マトリックスの世界市場2023年：動物由来、ヒト由来
  • 人工膝関節置換術の世界市場2023年：脛骨コンポーネント、大腿骨コンポーネント、膝蓋骨コンポーネント
  • 食事代替バーの世界市場2023年：ナッツ類、果物/野菜シリアルバー、その他
  • 食事代替朝食用お粥の世界市場2023年：バレル、箱入り
  • ヒト用気道管理装置の世界市場2023年：気管内チューブ、ラリンジアルマスク、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7584 )"ヒト由来無細胞＆真皮置換の世界市場2023年：ヒト真皮、ヒト胎盤膜" (英文：Global Acellular and Dermal Replacement from Human Source Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。